Cart
sales@molnova.com
Foropafant
CAS No. 136468-36-5
Foropafant( SR27417 )
Catalog No. M26689 CAS No. 136468-36-5
Foropafant is a highly potent and selective platelet-activating factor (PAF) receptor antagonist (Ki: 57 pM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | Get Quote |
|
| 10MG | 282 | Get Quote |
|
| 25MG | 480 | Get Quote |
|
| 50MG | 691 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameForopafant
-
NoteResearch use only, not for human use.
-
Brief DescriptionForopafant is a highly potent and selective platelet-activating factor (PAF) receptor antagonist (Ki: 57 pM).
-
DescriptionForopafant is a highly potent and selective platelet-activating factor (PAF) receptor antagonist (Ki: 57 pM). Foropafant potently inhibits the PAF-induced aggregation of rabbit and human platelets.
-
In Vitro——
-
In Vivo——
-
SynonymsSR27417
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number136468-36-5
-
Formula Weight464.72
-
Molecular FormulaC28H40N4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (215.18 mM)
-
SMILESCC(C)c1cc(C(C)C)c(-c2csc(n2)N(CCN(C)C)Cc2cccnc2)c(c1)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen T, et al. Iron(iii) chloride hexahydrate-promoted selective hydroxylation and chlorination of benzyl ketone derivatives for the construction of hetero-quaternary scaffolds. Org Biomol Chem. 2016 Oct 18;14(41):9859-9867.
molnova catalog
related products
-
Letaplimab
Letaplimab (IBI-188) is a humanized IgG4 class antibody targeting CD47 and is often used in combination with azacitidine for the treatment of primary diagnosis of intermediate- to high-risk myelodysplastic syndromes.
-
Bruceine E
Bruceine E is isolated from B. javanica seeds with hypoglycemia effects. Bruceine E can be used for studies about acting as an insulin secretagogue.
-
RET-IN-1
RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552.
